Latham BioPharm Group, part of SIA Partners, today announced receiving a new Indefinite Delivery, Indefinite Quantity (IDIQ) contract award from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), titled Preclinical Services for Biopharmaceuticals Product Development.

iTOL-100 technology has broad applicability and can be applied to both allogenic and stem cell-derived organoids across a number of diseases.

Manufacturing agreement supports advancement of iTolerance's development of iTOL-100 towards first in human clinical study for lead program, iTOL-102.

Gb Sciences' anxiety formulations were previously identified using the company's AI-driven PhAROS™ platform, and they have now been evaluated using preclinical zebrafish models of stress at the National Research Council of Canada.

R. Douglas Hulse and Gordon V. Ramseier to Lead BCI LifeSciences LLC

Move aligns with core strategic capabilities and U.S. growth

As a world leader in cell line manufacturer and provider, Creative Diagnostics is now offering a portfolio of stable cell lines expressing biosimilars with its unique gene screening and amplification system.

The strong growth of the global biologicals market is expected to create a huge demand for efficient cold chain logistic services.

A new report from IMARC Group expects the market for cold chain logistic services to grow at a CAGR of 8% during 2011-2017.